Hormone difference may be important as higher levels of IGF-I have been associated with higher risks of colorectal, breast, and prostate cancer [24] and higher levels of free testosterone have been associated with prostate cancer [25] and postmenopausal breast cancer [26]. Here, IGF1 is linked to breast carcinoma.